StockData

Guardant Health vs Labcorp

GH and LH side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How GH and LH compare

Labcorp is the larger company, worth 1.5 times as much as Guardant Health ($30.2B against $20.4B).

Guardant Health grew revenue faster over the last twelve months (41.7% versus 6.0% for Labcorp).

Labcorp keeps more of each dollar of sales as profit, with a net margin of 6.9% compared with −37.9% at Guardant Health.

Labcorp pays a dividend yielding 0.77%; Guardant Health does not pay one.

Labcorp scores higher on the StockData Score (11 against 10 for Guardant Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricGHLH
Size and price
Market cap$20.4B$30.2B
Share price$151.70$372.32
Change, 1 year55.0%38.8%
Change, 5 years55.5%31.4%
Beta (5Y)1.620.59
Employees2,50671K
StockData Score
Total score1011 (better)
Valuation score00
Growth score4 (better)2
Performance score12 (better)
Health score5 (better)4
Dividend score03 (better)
Valuation
P/E–30.5×
P/S15.9×2.1× (better)
P/B–3.4×
EV/EBITDA–16.2×
P/FCF–23.5×
FCF yield−1.1%4.3% (better)
Fair value–$317.92
Margin of safety–−17.1%
Growth
Revenue growth (TTM)41.7% (better)6.0%
Revenue growth, 5Y average27.9% (better)−0.04%
Net income growth (TTM)–17.4%
EPS growth (TTM)–19.6%
EPS growth, 5Y average–−8.0%
Profitability
Gross margin65.2% (better)29.0%
Operating margin−39.4%10.3% (better)
Net margin−37.9%6.9% (better)
FCF margin−18.2%8.8% (better)
Return on equity–11.4%
Return on invested capital–8.6%
Financial health
Debt / equity–0.66
Net debt / EBITDA–2.53
Interest coverage−96.6×6.5× (better)
Current ratio3.60 (better)1.41
Altman Z-score3.58 (better)3.57
Piotroski F-score67 (better)
Dividends and buybacks
Dividend yield–0.77%
Payout ratio–23.6%
Years of dividend growth–0
Buyback yield0.00%2.2% (better)
Shareholder yield0.00%3.0% (better)
Ownership
Held by institutions99.8%97.9%
Held by insiders1.8%0.39%
Insider net buying, 12 months−$173M−$11.7M (better)
Superinvestors holding–1
Short interest, % of float7.2%3.1%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.